LNTH - William Blair downgrades Lantheus to market perform
2023-12-19 14:14:12 ET
More on Lantheus
- Lantheus: SPLASHdown, Navigating Waves In MCRPC Treatment
- Lantheus Holdings: Huge Catalysts Ahead And Cheap Valuation
- Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Call Transcript
- Lantheus, Point BioPharma drop amid results of SPLASH study on prostate cancer
- Eli Lilly surprised as POINT Biopharma acquisition remains incomplete
For further details see:
William Blair downgrades Lantheus to market perform